COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 2 of 2 for:    AB Science | Amyotrophic Lateral Sclerosis and Masitinib

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03127267
Recruitment Status : Not yet recruiting
First Posted : April 25, 2017
Last Update Posted : April 6, 2020
Information provided by (Responsible Party):
AB Science

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : June 2022
Estimated Study Completion Date : September 2022